Consultant Medical Oncologist

Dr. Vishnu Vardhan Juture

Dr. Vishnu Vardhan Juture is a Consultant Medical Oncologist with expertise in the diagnosis and management of solid tumors and hematological malignancies. He is trained in advanced cancer therapies including chemotherapy, targeted therapy, and immunotherapy. Currently working at IRCS Cancer Hospital, Nellore, he provides personalized, evidence-based cancer care with a compassionate approach.

Personal Info

DDr. Vishnu Vardhan Juture is a dedicated Medical Oncologist with strong expertise in the diagnosis and management of solid tumors and hematological malignancies. With advanced training in medical oncology and a solid background in general medicine, he provides evidence-based, compassionate cancer care. He is currently associated with IRCS Cancer Hospital, Nellore, delivering personalized treatment plans and long-term patient support.

Speciality:
  • Medical oncology (solid tumors & hematological malignancies)

  • Chemotherapy & targeted therapy

  • Immunotherapy management

  • Cancer patient counseling & follow-up care

 

  • Supportive and palliative oncology care

Education:
  • DM (Medical Oncology) – Vydehi Institute of Medical Sciences, Bengaluru (2025)

  • MD (General Medicine) – SRM Medical College, Chennai (2018)

 

  • MBBS – Narayana Medical College, Nellore (2015)

Experience :
  • onsulting Physician – Apollo Hospital

  • Senior Resident, General Medicine – Narayana Medical College

  • Senior Resident, General Medicine – ESI Medical College Hospital

  • Assistant Professor, General Medicine – ACSR Medical College

  • Consultant Medical Oncologist – IRCS Cancer Hospital, Nellore

  • Professional Skills

    Dr. Vishnu Vardhan’s professional skills include comprehensive cancer diagnosis, chemotherapy planning, and multidisciplinary treatment coordination. He is experienced in managing complex oncology cases, monitoring treatment responses, and providing holistic care that focuses on both physical and emotional well-being of patients.

    100 %
    Chemotherapy & Targeted Therapy
    100 %
    Solid Tumor Management
    100 %
    Hematological Malignancies